lacking the CD11/CD18 integrins is marked by poor or absent accumulation ofPMNs at sites of bacterial infections . Stimulated PMNs from such patients fail to adhere to unactivated EC and to certain matrix proteins in vitro (3, [17] [18] [19] [20] . mAbs directed against the common /3 chain ofthe CDII/CD18 completely inhibit adherence of stimulated PMNs from normal donors to unactivated EC monolayers and to certain matrix proteins in vitro (3, 4, 6), and systemic administration of anti-C,Dll/CD18 antibodies to experimental animals inhibits tissue accumulation of PMNs in response to chemoattractants (21, 22) . These observations have demonstrated the importance of CD1I/CD18-dependent PMN-adhesive interactions in the directed migration of PMNs into sites of inflammation . However, PMNs can also adhere in vitro to certain surfaces, notably thrombin, LPS, or cytokine-stimulated EC monolayers, by mechanisms that do not require CD11/CD18 integrins (4, 5, 23) . The contribution of such CDII/CD18-independent PMN-adhesive interactions to PMN recruitment into inflammatory sites is still being characterized .
In the experiments reported here, we have investigated the receptors involved in stimulated PMN adherence to several extracellular matrix molecules in vitro. We have found that the adherence of stimulated PMNs to the majority of protein-coated surfaces tested can be totally inhibited by the anti-CD18 mAb, IB4. In contrast, stimulated PMN adherence to laminin, the major glycoprotein ofmammalian basement membrane, was only partially inhibited by mAb IB4. This CDll/CD18-independent adherence appears to involve a distinct PMN adherence receptor for laminin . These observations are important because interaction ofphagocytes with laminin and other interstitial proteins may alter their functional state (24) (25) (26) , in addition to influencing directed migration .
Materials and Methods
Buffers and Reagents.
Human serum albumin for infusion (HSA; Cutter Biologicals, Berkeley, CA), recombinant human C5a (C5a), FMLP, PMA (Sigma Chemical Co., St. Louis, MO), platelet activating factor (PAF; Avanti Polar Lipids, Inc., Birmingham, AL), gelatin (Type II from swine skin; Fisher Scientific Co., Pittsburgh, PA), and purified human plasma fibronectin (Collaborative Research, Lexington, MA) were purchased . Recombinant human TNFa was a gift from Cetus Corp. (Emeryville, CA). Murine laminin and collagen IV purified from the EHS sarcoma, and DPGYIGSR peptide, were gifts of Dr. Hynda Kleinman (National Institute of Dental Research, Bethesda, MD) . Synthetic GRGDSP peptide was purchased (Telios Pharmaceuticals, La Jolla, CA) . HBSS and HBSS containing 1.2 mM Ca2' and 0.8 mM Mg 2' (HBSS2') were purchased from M.A. Bioproducts (Walkersville, MD) .
Antibodies .
Murine mAb IB4 (IgG2a), which binds to the a chain (CD18, 02 of the integrin family) of the CDII/CD18 (27) , was a gift from Dr. Samuel Wright (Rockefeller University, NY) . Murine mAb B6H12 (IgGI), which recognizes the RGDS-binding leukocyte response integrin (25) was a gift from Dr. Eric Brown (Washington University, St. Louis, MO) . Murine mAb W6/32 (IgG2a), which recognizes a common determinant on the HLA class I molecule (28) ; rat mAb M1/70 (IgG2b), which recognizes the a2 chain of the CDll/CD18 (CDllb, Mac-1, or CR3; 15) ; and rat mAb R4-6A2 (IgGI), directed against murine IFN-'y (29), were obtained from the American Type Culture Collection (Rockville, MD) . AIIB2 and BIVF2 are rat mAbs raised against the JAR choriocarcinoma cell line (30) . AIIB2 (IgGl) and mAb 13 (rat IgG2a; 31) bind to the 0 subunit (0i) of the VLA integrins . BIVF2 is a control mAb (IgG2a) that binds to the JAR cell but does not recognize an integrin. The various mAbs used in these experiments are summarized in Table I . IB4 was purified from ascites using protein A-Sepharose . W6/32 and B6H12 were purified from ascites by octanoic acid precipitation (32) . Ml/70, AIIB2, and BIVF2 were used as tissue culture supernatants . R4-6A2 was partially purified by (NH4)2SO4 precipitation from tissue culture supernatant, while mAb 13 was purified from tissue culture supernatant by (NH4)2SO4 precipitation and ion exchange chromatography.
Subclass determination of AIIB2 and BIVF2 was performed with a commercially available kit (The Binding Site, San Diego, CA) . The concentrations of mAbs in tissue culture supernatant were determined by ELISA, using rat IgG (Calbiochem-Behring Corp., LaJolla, CA) as a standard.
Rabbit polyclonal antiserum against the 67-kD laminin receptor was a gift from Dr. Tomeo Sequi-Real (National Institute of Dental Research) . Rabbit antibody against laminin, and F(ab')2 fragments of the IgG fraction, were prepared as previously described (24) .
EC Monolayers and Subendothelial Matrix. Confluent primary monolayers of human umbilical vein EC were prepared as previously described in 24-mm tissue culture plastic wells (4, 33, 34) . Subendothelial matrices were prepared by lysis of the overlying endothelial monolayers with 0.5% Triton X-100 for 30 min at 37°C, followed by treatment with 0.1 M NH40H for 10 min at room temperature (34). The Subendothelial matrices were then washed copiously with HBSS before use in the adherence assay.
PMN Adherence Assay. The method for determining PMN adherence to protein-coated plastic wells and to endothelial cell monolayers has been previously described in detail (4, 33, 34). PMNs were obtained from healthy adult donors, or from a patient with leukocyte adhesion deficiency (CDII/CD18 deficiency) . The clinical and laboratory characteristics of the patient with CDII/CD18 deficiency will be the subject ofa more complete report (Shigeoka, A. 0., and J. F Bohnsack, manuscript in preparation) . Briefly, this female patient's clinical course has been characterized by recurrent cutaneous infections with no pus formation and a peripheral blood leukocytosis since her first several months of life. PMNs from this patient completely lack detectable CD11/CD18 as determined by using flow cytometry or by immunoprecipitation, using mAb IB4 to detect the /3 chain of the CDII/CD18 complex. PMNs were isolated from heparinized blood by dextran sedimentation, hypotonic lysis, and FicollHypaque density gradient centrifugation, as previously described (4, 33, 34) . Purified PMNs were suspended in HBSS2' containing 0.5% HSA (HBSS"/HSA) and labeled with "'Indium oxine ('"In) by incubation with the "'In for 5 min at 37°C, followed by washing to remove free "'In. '"In-labeled PMNs were suspended to 5.5 x 106/ml in HBSS2'/HSA . For adherence to protein-coated substrates, 16-mm plastic tissue culture wells (Nunc, Roskilde, Denmark) were coated with purified protein by incubation of 500 111 of protein diluted in HBSS for at least 2 h at 37°C. The wells were then aspirated and washed once with HBSS just before the adherence assay. Preliminary studies revealed that PMNs adhere readily to uncoated tissue culture plastic wells, likely by a charge-induced mechanism . This high basal adherence was inhibited in a concentration-dependent manner by precoating the wells with a variety of proteins . Maximal inhibition of basal adherence occurred when wells were precoated with proteins at 50 11g/ml . All proteins were therefore used at 50 lag/ml to coat the wells, and basal adherence was found to be approximately equal to all protein-coated wells used in this report (see Results) . Adherence to endothelial cell monolayers and subendothelial matrices was determined in 24-mm diameter wells prepared as described above.
PMNs were preincubated with mAb for 10 min at room temperature before addition to the wells . mAbs were present throughout the course of the incubation. "In-PMNs (2251e1) were added to 16-mm wells and 4501x,1 of "'In-PMNs to 24-mm wells, followed by addition of 25 or 50111, respectively, ofthe different agonists. The PMNs were then allowed to adhere for various lengths oftime at 37°C. At the end of the incubation interval, nonadherent cells were removed by gentle aspiration and one wash with 0.5 ml HBSS. Nonadherent cells were saved and counted . Counts associated with adherent cells were recovered by two cycles of lysis with 1 M NH40H and vigorous scraping with a cotton tip applicator. The percentage ofadherent cells was calculated as a percentage ofthe total number ofcounts added to each well.
In experiments to determine the requirements for divalent cations for PMN adherence, PMNs prepared in HBSS2'/HSA were pelleted by centrifugation and resuspended in HBSS/HSA containing either EGTA, CaC12, or MgC12 at a final concentration of 1 mM.
In experiments to determine the receptor responsible for CD11/CD18-independent adherence, I I 'In-PMNs isolated from normals were incubated at 1.1 x 106/ml, with mAb IB4 at 50 11g/ml to maximally inhibit CDII/CD18-dependent adherence. PMA-stimulated adherence to laminin in the presence of IB4 was compared in paired experiments to PMA-stimulated Immunopnvipitation of?5ISurface-labeled PMNs. Purified human PMNs were washed four times in PBS, pH 7.4. PMNs (1-2 x 108) were labeled with 2 mCi of Na' 25I for 15 min using 250 Ag of chloroglycoluril (35; Sigma Chemical Co.), washed four times with PBS containing 2 mM KI, and solubilized in 0.01 M Tris, 0.145 M NaCl, pH 7.4, containing 0.5 mM EDTA, 25 wM nitroparaguanidinobenzoate, 2 leg/ml aprotonin, and 2 Rg/ml leupeptin (lysis buffer) for 30 min at 37°C. After the solubilization, the lysates were centrifuged for 10 min in a microfuge to remove insoluble material, and precleared successively with Sepharose 4BCL and protein A-Sepharose. Aliquots of precleared cell lysates were mixed with AIIB2 (1 14g), mAb 13 (5 IAg), or BIVF2 (1 j ug) for 1 h at 4°C. Immune complexes were precipitated with 50 Ftl of goat anti-rat IgG agarose (Sigma Chemical Co.). After mixing for 2 h at 4°C, the precipitates were washed exhaustively with lysis buffer, and the pellets boiled in sample buffer for SDS-PAGE. SDS-PAGE was performed according to the method of Laemmli (36) using an 8% resolving gel and 4% stacking gel . Reduced samples were treated with 2% 2-ME.
Flow Cytometry. Purified PMNs (106 in 0.5 ml of HBSS/HSA) were incubated with mAbs for 30 min on ice, washed twice, and then incubated with fluorescein-labeled goat anti-rat antibody for an additional 30 min on ice . The cells were then washed, fixed with 2 % paraformaldehyde in 0.01 M P04, 0.145 M NaCl, pH 7.4, and analyzed on a Cytofluorograph II (Ortho Diagnostic Systems Inc., Westwood, MA).
Statistical Analysis. Significance was determined using student's t-test for paired and unpaired samples .
Results
Phorbol-stimulated PMNs Adhere to Matrix Proteins. We previously demonstrated that stimulated human PMNs adhere in an enhanced fashion to complex subendothelial matrices (14, 34) . To examine the role of specific proteins in this interaction, we assayed the adhesion of radiolabeled PMNs to matrices of laminin, collagen IV, fibronectin, and gelatin, as well as to complex subendothelial matrices and EC monolayers ( Fig. 1 ). There was very low adhesion of unstimulated PMNs to each surface ("basal adhesion"). This demonstrates that unstimulated PMNs from the peripheral circulation do not avidly adhere to surfaces, and that exposure ofunstimulated PMNs to these proteins or to unstimulated EC does not alone significantly increase PMN adherence . When PMNs were stimulated with PMA, there was a dramatic (4-10-fold) increase in adhesion; enhanced adhesion occurred when laminin, collagen IV, or fibronectin was the substrate, as well as with complex subendothelial matrices . This result suggests that one or more ofthese proteins, which are major components of the subendothelium (37), is a "target" for adhesive molecules on the surface of stimulated PMNs . To examine the mechanism ofrecognition ofthe proteins by activated PMNs, we determined the effect of the anti-CD18 mAb, 1114, on stimulated adherence ofPMNs to these surfaces, since we previously showed that PMNs stimulated with chemotactic4actors adhere to a variety of proteins by a CD11/CD18-dependent mechanism (4, 14). IB4 prevented enhanced PMA-stimulated PMN adherence to fibronectin, gelatin, and collagen IV, as well as to EC (Fig. 1 ). An isotypematched control mAb, W6/32, had no effect on stimulated PMN adherence (not shown). This result supports previous observations that indicate that CD11/CD18 glycoproteins can interact with a variety ofsoluble and cell surface-associated ligands (3, 4, 38-42) . In contrast, the percentage of PMA-stimulated PMNs adhering to subendothelial matrices was reduced by only 35% by 1114 (Fig. 1) . Furthermore, there was 1114-resistant adherence of PMA-stimulated PMNs to laminin (Fig. 1) , suggesting that laminin confers this property on the subendothelial matrix . Therefore, we further characterized the mechanisms of stimulated PMN adherence to laminin .
Laminin Is Recognised by Stimulated PMNs. A trivial explanation for the IB4-resistant binding was that laminin did not coat the plastic surface evenly, allowing PMNs to bind to exposed plastic (see Materials and Methods) . Phase-contrast microscopy demonstrated, however, that stimulated PMNs were uniformly distributed over the laminin-coated wells, arguing against this possibility. Furthermore, F(ab')2 fragments ofpolyclonal IgG antibody directed against laminin completely abolished the 1114-resistant adherence of PMA-stimulated PMNs to wells coated with laminin, whereas F(ab')2 fragments of preimmune IgG did not affect the IB4-resistant adherence (not shown). In a second strategy, we prepared composite matrices that con-tained both laminin and collagen IV. In these experiments, tissue culture wells were first coated with collagen IV, washed, and then incubated with either laminin or buffer. After an additional incubation, the wells were again washed and the adherence of PMA-stimulated PMNs was examined in the presence or absence of IB4. Laminin binds specifically to collagen IV (43) , and laminin bound to the collagen IV-coated wells supported IB4-resistant adherence ofPMA-stimulated PMNs (Fig.  2 ). These data demonstrate that the IB4-resistant adherence ofthe stimulated PMNs resulted from an interaction of the PMNs with the laminin molecule itself.
Stimulated PMNs Adhere to Laminin by CDII/CD18-dependent and CI)11/CDIS-independent Mechanisms. PMA-stimulated PMN adherence to laminin was time dependent, with an onset within 5 min and maximal adherence at 30-60 min (Fig. 3) . IB4-resistant adherence was present at 5 min and increased with time (Fig . 3) . Increasing the concentration of IB4 from 10 to 50 wg/ml did not abolish PMA-stimulated PMN adherence to laminin (from 56 t 8 to 46 t 15% with 10 and 50 I~g/ml of IB4, respectively). Preincubating the PMNs with IB4 at 30 FAg/ml at 37°C with constant agitation for 90 min also did not lead to a further reduction in PMA-stimulated PMN adherence to laminin when compared with PMA-stimulated adherence ofPMNs not preincubated with IB4 (Table II) . In the latter experiments, we followed the protocol that Nathan et al. (44) used to demonstrate that the massive respiratory burst produced by TNFstimulated PMNs adherent to extracellular matrix proteins is CD11/CD18 dependent. These data suggest that the IB4-resistant PMN adherence to laminin did not merely reflect a higher affinity of'larninin for the CD11/CD18.
To examine this issue in a different way, we measured the stimulated adherence of PMNs from a patient with leukocyte adhesion deficiency. These PMNs, which completely lack CDII/CD18 on their surface either in the basal state or after treatment with PMA (as measured by analysis with flow cytometry using anti-CD11b and anti-CD18 mAb), were less adherent to lamininthan were control PMNs (Table  III) . This observation further demonstrates that the CD11/CD18 contributes to PMN FIGURE 2. Laminin bound to collagen IV supports IB4-resistant adherence. Tissue culture wells were coated with collagen IV (50 pg/ml), then washed, and either laminin or buffer was added. After an additional incubation, the plates were washed and adherence tested in the presence or absence of PMA (10 ng/ml) and mAb IB4 (10 Wg/ml). Data are the means t SD from four separate experiments . (') p < 0.01, compared with basal adherence to the same substrate. adherence to laminin. However, there was a three to fourfold increase in adhesion of PMA-stimulated PMNs from the CDll/CD18-deficient patient to laminin, whereas there was no increased adhesion to gelatin or EC (Table III) . These data demonstrate that PMA-stimulated PMNs adhere to laminin by a mechanism that does not require expression or upregulation of the CD11/CD18. The Expression of CD111CD18-independent PMNAdhesion to Laminin Is Agonist Specoc and Dependent on the Presence of Divalent Cations. Several other agonists were examined for their ability to stimulate CDll/CD18-independent adherence to laminin. As shown in Fig. 4 , FMLP, PAF, and recombinant human C5a all stimulated PMN adherence to laminin. This adherence was completely CD1I/CD18 dependent when assayed after a 30-min incubation . In contrast, calcium ionophore A23187 and TNFtx both stimulated PMN adherence to laminin in a CDll/CD18-independent manner, but not to the same extent as did PMA (Fig. 4) . Thus, an agonist important in inflammatory tissue injury, TNF-ci (45), as well as pharmacologic agonists (PMA, calcium ionophore), induced CD11/CD18-independent PMN adhesion to laminin, whereas all the chemotactic factors induced adhesion that was completely mediated by the CD11/CD18. Resuspending the PMNs in buffer without added divalent cations completely inhibited PMA-stimulated adherence to gelatin but not to laminin (Fig. 5) . This adherence to laminin was completely CD11/CD18 dependent (inhibited by 04), and was probably supported by the small amount of divalent cation remaining in the buffer since chelation of divalent cations with EGTA completely abolished the ad-FIGURE 4 . The expression of IB4-resistant PMN adherence to laminin is agonist dependent . The ability of IB4 (10 lAg/ml) to inhibit adherence of PMNs stimulated with various agonists was tested on laminin substrates. IB4 completely inhibited adherence of PMNs to laminin stimulated with FMLP at 10-6 M, PAF at 10 -6 M, or recombinant human C5a at 100 ng/ml, but did not completely inhibit adherence stimulated by recombinant TNRa at 10 -9 M, or calcium ionophore A23187 at 500 ng/ml . IB4 completely inhibited PMN adherence to gelatin for every agonist tested. The number of experiments performed for each separate experiment is indicated in parentheses. (') p < 0 .01 compared with basal adherence to laminin . herence of PMA-stimulated PMNs to laminin (Fig. 5 ). The addition of 1 mM Mgt+ , but not 1 mM Ca2+ , restored PMN adherence to gelatin. This concentration of Mgt' also supported CDII/CD18-dependent adherence of PMNs to laminin, whereas CDII/CD18-independent adherence did not occur in the presence of 1 mM Ca2" alone (Fig . 5 ). These data demonstrate that CDII/CD18-independent adherence to laminin is Mgt' dependent.
CD111CD18-independent PMNAdherence to Laminin Is Inhibited by Anti-VLA mAbs . We next attempted to determine what alternative adherence receptor mediates CD11/CD18-independent PMN adherence to laminin. We found that neither polyclonal antibody directed against the 67-kD laminin receptor present in PMN granules (46), nor DPGYIGSR peptide, a sequence in laminin that binds to the 67-kD receptor (47) , inhibited CDII/CD18-independent adherence (not shown) . We then considered members of the 0-1 integrin family, since at least three of these,VLA-2, VLA-3, and VLA-6, have been shown to mediate cell adhesion to laminin (48) (49) (50) . mAb AIIB2 and mAb 13, which bind to the common /3t subunit of the VLA family of integrins, significantly inhibited adherence of normal PMNs to laminin when the mAb IB4 was used to block CDII/CD18-dependent adherence (Fig. 6) . In experiments similarto those shown in Fig. 6 , mAb 13 inhibited CD11/CD18-independent FIGURE 6 . Anti-0I mAbs significantly inhibit CDII/CD18-independent adherence to laminin . Adherence of PMNs to laminin after 30 min in the presence of PMA at 10 ng/ml and IB4 at 50,ug/ml was compared with adherence of PMAstimulated PMNs to laminin in the presence of IB4 and various mAbs, rat IgG, or peptide GRGDSP Final concentrations of AIIB2 and BIVF2 were 2 Fig/ml, while mAb 13, W6/32, B6H12, and rat IgG were at 50 gg/ml . GRGDSP was used at a final concentration of 300 hg/ml . Numbers in parentheses indicate the number of separate experiments . (') p < 0 .01 compared with paired experiments with PMA + IB4 only.
adherence at concentrations as low as 2 Ag/ml, but inhibition was most consistent at concentrations >,10 /,tg/ml . In the absence of IB4, neither AIIB2 nor mAb 13 inhibited PMA-stimulated adherence of PMNs from normal donors to laminin (not shown) . Polyclonal rat IgG, synthetic peptide GRGDSP, and mAbs BIVF2, W6/32, and B6H12 did not inhibit CD11/CD18-independent adherence (Fig. 6) .
The effect of the anti-Rt mAbs was most clearly observed when adherence of PMNs from the CDII/CD18-deficient patient was examined . PMA-stimulated adherence of PMNs to laminin in this non-CD11/CD18-mediated system was completely blocked by mAb AIIB2 (Table IV) and by mAb 13 (Fig. 7) . Inhibition by mAb 13 was concentration dependent, with complete inhibition occurring at concentrations of mAb 13 >,10 hg/ml (Fig. 7) . The control mAbs BIVF2 and W6/32 did not inhibit adherence of CDII/CD18-deficient PMNs to laminin (Table IV and Fig. 7) . mAb AIIB2 Recognizes a Receptor on the Surface of PMNs. We determined whether AIIB2 and mAb 13 recognize an antigen on PMNs, since it has previously been reported that PMNs do not possess VLA receptors on their surface (51) . Both mAb AIIB2 and mAb 13 immunoprecipitated a protein from t25I surface-labeled PMNs. Under both reducing and nonreducing conditions, the immunoprecipitate migrated on SDS-PAGE as a broad band with an Mr of -125,000-135,000 daltons (Fig. 8) . Adherence of PMNs from a CD11/CD18-deficient patient to laminin in the presence or absence of PMA at 10 ng/ml was determined after a 30-min incubation as described in Materials and Methods . PMNs were preincubated with tissue culture supernatant containing mAb AIIB2 or BIVF2 for 10 min before and throughout the course of the adherence assay at a final concentration of 2 Fig/ml This band was clearly distinguishable from the VLA antigens (VLA-2, VLA-5, and VLA-6; 52) present on platelets, which appeared as two bands at 135,000-140,000 and 115,000-120,000 daltons (Fig. 8 ). In addition, experiments with flow cytometry indicate that both mAbs 13 and AIIB2 specifically bind to PMNs (Fig. 9 ). These data demonstrate that the anti-a1 mAbs both identify a surface protein on PMNs and block PMN adhesion to laminin, indicating that human PMNs possess a surface receptor, distinct from the CDII/CD18, that mediates adherence to this basement membrane protein. This distinct PMN adherence receptor appears to be a member of the 01 family of integrins.
Discussion These experiments demonstrate that adherence of stimulated human PMNs to laminin involves the CD11/CD18 glycoprotein complex, since the anti-CD18 mAb, IB4, decreased agonist-stimulated PMN adherence to laminin. However, laminin possesses a unique property as an adherence substrate for stimulated PMNs, since Flow cytometry of PMNs from normal donors stained with anti-/31 mAb 13 (3 kg) or A1IB2 (1 pg), anti-CD116 mAb Ml/70 (12 pg), or the control mAbs BIVF2 (3 wg ; left) or R4-6A2 (I hg; right) . See Materials and Methods for details of experimental procedures . Fluorescence intensity is expressed on a three-decade log scale.
adherence of PMA-stimulated PMNs to laminin, and laminin-containing subendothelial matrix, was only partially inhibited by mAb IB4, whereas PMA-stimulated PMN adherence to all other surfaces tested was completely inhibited by IB4. There were at least two possible explanations for the difference between PMAstimulated PMN adherence to laminin and adherence to the other substrates examined . One possibility was that CDII/CD18 mediates both the 1134-sensitive and IB4-resistant adherence to laminin, but that the affinity of CDII/CD18 for laminin was greater than for the other ligands, such as gelatin or fibronectin. This explanation seems unlikely since even very high concentrations of IB4 and prolonged preincubation of PMNs with IB4 at 37°C failed to inhibit the PMA-stimulated PMN adherence to laminin. In addition, PMA induced PMNs from a CDIl/CD18-deficient patient to adhere to laminin-coated substrates, but not to gelatin or endothelial cell monolayers, documenting that adhesion to laminin occurs in the absence of leukocyte 02 integrins.
The alternative explanation, therefore, is that there is a separate PMN receptor for laminin. A member of the VLA integrin receptor family would be a good candidate to be such a PMN laminin receptor since several members of the VLA family, VLA-2, VLA-3, and VLA-6, have been reported to mediate adherence of connective tissue cells and platelets to laminin substrates (48) (49) (50) . Furthermore, integrins require divalent cations for ligand binding (16) , and CD11/CD18-independent adherence to laminin requires the presence of the divalent cation Mgt' for expression (Fig. 5) . Indeed, we found that mAbs 13 and AIIB2, which recognize the common al subunit of the VLA integrins, significantly inhibited the CD11/CD18-independent adherence of PMA-stimulated PMNs to laminin.
It has previously been reported that VLA receptors are not present on mature PMNs, since flow cytometry experiments did not detect binding of the anti-al mAb AIA5 to PMNs (51) . By contrast, our flow cytometry experiments indicate that mAbs 13 and AIIB2 do bind to PMNs, although the observed fluorescence intensity indicates that the antigen recognized by mAbs 13 and AIIB2 is present on the surface of unstimulated PMNs at low density. It is interesting to note that both mAbs 13 and AIIB2 differ from AIA5 in that both mAb AIIB2 and mAb 13 block adherence of cells to several extracellular matrix molecules (31, 53) , suggesting that these mAbs have a different affinity for the VLA a chain, or that they bind to a separate epitope on the 01 chain than mAb AIA5 . We also found that these anti-(31 mAbs immunoprecipitate a protein from surface-labeled PMNs . Interestingly, this precipitate does not contain a band that migrates like the ,(31 chain immunoprecipitated from surface-labeled platelets. There are several possible explanations for the discrepancy. One is that the mAbs crossreact with a nonVLA molecule on PMN cell surface membranes. Ifso, our functional data indicate that this molecule mediates cell binding to laminin, identifying it as a novel receptor for matrix proteins . Another possibility is that the /3 chain is poorly labeled on PMNs by the method we have used, and only the a chain is recognizable on the autoradiograms . Finally, the VLA 0 chain from PMNs may have a different M, from that in platelets, due, for example, to differences in glycosylation . Ifso, the broad band seen in Fig. 8 may be the (3 chain, or a closely spaced dimer of a and (3 chains. These possibilities are currently under investigation.
These observations clearly demonstrate that PMNs have at least two separate mechanisms by which they adhere to laminin, one that is CDII/CD18 dependent and one that is mediated by an independent laminin receptor that has similarity to a VLA /31 integrin. These findings confirm that PMNs can adhere by CD11/CD18-independent mechanisms (4, 5, 23). It is not clear what contribution such CDII/CD18-independent adherence makes to PMN recruitment into sites of inflammation . The inability of PMNs from CD11/CD18-deficient patients to accumulate at sites of infection suggests that the CD11/CD18 is a dominant and critical receptor involved in PMN adherence and migration in vivo. However, PMNs may utilize regulated expression ofdifferent surface receptors to allow controlled adhesion to different structures (endothelial cells, connective tissue proteins, epithelial cells ofthe airway, peritoneum, etc.) that are encountered as they migrate to extravascular sites. The surface molecule that we describe may be such a receptor. In addition, distinct PMN receptors for extracellular matrix proteins, such as the PMN receptor for laminin described here or the recently described PMN RGDS integrin (25) , may allow the PMN to discriminately recognize its extravascular environment, and alter its functional state accordingly (24) (25) (26) .
Summary
We used mAbs against polymorphonuclear leukocyte (PMN) surface proteins to investigate the mechanisms by which stimulated human neutrophils (PMNs) adhere in vitro to laminin, the major glycoprotein ofmammalian basement membrane. mAb IB4, which is directed against the common (32 chain of the CD11/CD18, only partially inhibited the adherence of PMA-stimulated PMNs to both laminin and to subendothelial matrices. In contrast, IB4 completely inhibited PMA-stimulated PMN adherence to gelatin, fibronectin, collagen IV, and endothelial cell monolayers . PMA-stimulated PMNs from a patient with severe congenital CD11/CD18 deficiency also adhered to laminin, but not to gelatin or endothelial cell monolayers. Therefore, PMA-stimulated PMNs adhere to laminin by both CDII/CD18-dependent and CDII/CD18-independent mechanisms . Expression of CD11/CD18-independent adherence to laminin was agonist dependent, occurring after stimulation with the cal-cium ionophore A23187 and recombinant TNRa, but not with the chemotactic factors FMLP, platelet activating factor, or recombinant human C5a. Expression of CD11/CD18-independent adherence was also divalent cation dependent, occurring in the presence of Mgt' but not Cat+ as the sole added divalent cation. The mAbs AIIB2 and 13, which are directed against the 01 subunit of the VLA integrins, significantly inhibited the CD11/CD18-independent adherence of normal PMNs to laminin, and completely abolished the adherence of CD11/CD18-deficient PMNs to laminin . Both anti-(31 mAbs bound to PMNs, as demonstrated by flow cytometry, and immunoprecipitated a membrane molecule of M, 130,000 daltons from 125 1-labeled, detergent-solubilized PMNs. These data suggest that human PMNs possess (31 and 02 classes of integrins, and that both mediate PMN adherence .
